CD226 and metastatic melanoma: Interestingly, CD8+ TILs downregulated CD226, the costimulatory counterpart to TIGIT, supporting an imbalance of TIGIT/CD226 expression in metastatic melanoma, which may contribute to melanoma-induced T cell dysfunction.